Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1932 1
1933 1
1959 1
1963 1
1965 2
1966 5
1967 1
1971 1
1972 3
1975 1
1979 2
1981 1
1982 3
1983 3
1984 4
1985 4
1987 4
1988 5
1989 7
1990 12
1991 11
1992 11
1993 6
1994 9
1995 7
1996 7
1997 9
1998 6
1999 9
2000 24
2001 22
2002 28
2003 19
2004 20
2005 42
2006 50
2007 56
2008 89
2009 111
2010 119
2011 132
2012 168
2013 212
2014 266
2015 250
2016 309
2017 329
2018 304
2019 403
2020 526
2021 731
2022 763
2023 749
2024 361

Text availability

Article attribute

Article type

Publication date

Search Results

5,483 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for india sahu
Search for Bindia Sahu instead (1 results)
Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17).
Anjana RM, Unnikrishnan R, Deepa M, Pradeepa R, Tandon N, Das AK, Joshi S, Bajaj S, Jabbar PK, Das HK, Kumar A, Dhandhania VK, Bhansali A, Rao PV, Desai A, Kalra S, Gupta A, Lakshmy R, Madhu SV, Elangovan N, Chowdhury S, Venkatesan U, Subashini R, Kaur T, Dhaliwal RS, Mohan V; ICMR-INDIAB Collaborative Study Group. Anjana RM, et al. Lancet Diabetes Endocrinol. 2023 Jul;11(7):474-489. doi: 10.1016/S2213-8587(23)00119-5. Epub 2023 Jun 7. Lancet Diabetes Endocrinol. 2023. PMID: 37301218
BACKGROUND: Non-communicable disease (NCD) rates are rapidly increasing in India with wide regional variations. We aimed to quantify the prevalence of metabolic NCDs in India and analyse interstate and inter-regional variations. METHODS: The Indian Council of Medica …
BACKGROUND: Non-communicable disease (NCD) rates are rapidly increasing in India with wide regional variations. We aimed to quantify …
Genomics of rare genetic diseases-experiences from India.
GUaRDIAN Consortium; Sivasubbu S, Scaria V. GUaRDIAN Consortium, et al. Hum Genomics. 2019 Sep 25;14(1):52. doi: 10.1186/s40246-019-0215-5. Hum Genomics. 2019. PMID: 31554517 Free PMC article. Review.
Genomics-based approaches have been demonstrated to accelerate the diagnosis of rare genetic diseases and reduce the socio-economic burden. The Genomics for Understanding Rare Diseases: India Alliance Network (GUaRDIAN) stands for providing genomic solutions for rare disea …
Genomics-based approaches have been demonstrated to accelerate the diagnosis of rare genetic diseases and reduce the socio-economic burden. …
High-dose versus low-dose intravenous nitroglycerine for sympathetic crashing acute pulmonary edema: a randomised controlled trial.
Siddiqua N, Mathew R, Sahu AK, Jamshed N, Bhaskararayuni J, Aggarwal P, Kumar A, Khan MA. Siddiqua N, et al. Emerg Med J. 2024 Jan 22;41(2):96-102. doi: 10.1136/emermed-2023-213285. Emerg Med J. 2024. PMID: 38050078 Clinical Trial.
METHODS: This was an open-label randomised control trial conducted in a tertiary care teaching hospital in India from 11 November 2021 to 30 November 2022. Consenting participants were randomised to high-dose GTN or conventional low-dose GTN. ...CONCLUSION: In SCAPE, patie …
METHODS: This was an open-label randomised control trial conducted in a tertiary care teaching hospital in India from 11 November 202 …
Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India.
Prakash J, Sachdeva R, Shrivastava TP, Jayachandran CV, Sahu A. Prakash J, et al. Indian J Pharmacol. 2021 Mar-Apr;53(2):143-152. doi: 10.4103/ijp.ijp_901_20. Indian J Pharmacol. 2021. PMID: 34100398 Free PMC article. Review.
This article provides an overview of adverse events reporting tools in India vis-a-vis selected countries around the world, based on a comparative literature search. This article also throws light upon the regulatory aspects of PV in India, findings of PvPI and its …
This article provides an overview of adverse events reporting tools in India vis-a-vis selected countries around the world, based on …
Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2.
Naushin S, Sardana V, Ujjainiya R, Bhatheja N, Kutum R, Bhaskar AK, Pradhan S, Prakash S, Khan R, Rawat BS, Tallapaka KB, Anumalla M, Chandak GR, Lahiri A, Kar S, Mulay SR, Mugale MN, Srivastava M, Khan S, Srivastava A, Tomar B, Veerapandian M, Venkatachalam G, Vijayakumar SR, Agarwal A, Gupta D, Halami PM, Peddha MS, Sundaram GM, Veeranna RP, Pal A, Agarwal VK, Maurya AK, Singh RK, Raman AK, Anandasadagopan SK, Karuppanan P, Venkatesan S, Sardana HK, Kothari A, Jain R, Thakur A, Parihar DS, Saifi A, Kaur J, Kumar V, Mishra A, Gogeri I, Rayasam G, Singh P, Chakraborty R, Chaturvedi G, Karunakar P, Yadav R, Singhmar S, Singh D, Sarkar S, Bhattacharya P, Acharya S, Singh V, Verma S, Soni D, Seth S, Vashisht S, Thakran S, Fatima F, Singh AP, Sharma A, Sharma B, Subramanian M, Padwad YS, Hallan V, Patial V, Singh D, Tripude NV, Chakrabarti P, Maity SK, Ganguly D, Sarkar J, Ramakrishna S, Kumar BN, Kumar KA, Gandhi SG, Jamwal PS, Chouhan R, Jamwal VL, Kapoor N, Ghosh D, Thakkar G, Subudhi U, Sen P, Chaudhury SR, Kumar R, Gupta P, Tuli A, Sharma D, Ringe RP, D A, Kulkarni M, Shanmugam D, Dharne MS, Dastager SG, Joshi R, Patil AP, Mahajan SN, Khan AH, Wagh V, Yadav RK, Khilari A, Bhadang… See abstract for full author list ➔ Naushin S, et al. Elife. 2021 Apr 20;10:e66537. doi: 10.7554/eLife.66537. Elife. 2021. PMID: 33876727 Free PMC article.
To understand the spread of SARS-CoV2, in August and September 2020, the Council of Scientific and Industrial Research (India) conducted a serosurvey across its constituent laboratories and centers across India. ...
To understand the spread of SARS-CoV2, in August and September 2020, the Council of Scientific and Industrial Research (India) conduc …
State of the nation survey on cataract surgery in India.
Bali J, Bali O, Sahu A, Boramani J, Senthil T, Deori N. Bali J, et al. Indian J Ophthalmol. 2022 Nov;70(11):3812-3817. doi: 10.4103/ijo.IJO_1151_22. Indian J Ophthalmol. 2022. PMID: 36308101 Free PMC article.
PURPOSE: To study the knowledge, attitudes, and practices of the ophthalmologists in India regarding cataract extraction practices. METHODS: A prospective, online, descriptive study was conducted from January 2022 to April 2022 using a self-developed validated questionnair …
PURPOSE: To study the knowledge, attitudes, and practices of the ophthalmologists in India regarding cataract extraction practices. M …
Community-friendly tool to assess patient satisfaction in tuberculosis programme in the covid pandemic period; Bhubaneswar; India.
Kar S, Menberu M, Priyadarshini P, Sahu KS, Behera MR. Kar S, et al. Indian J Tuberc. 2023 Oct;70(4):483-488. doi: 10.1016/j.ijtb.2023.04.015. Epub 2023 Apr 23. Indian J Tuberc. 2023. PMID: 37968055 Review.
National Tuberculosis Elimination Programme (NTEP) is a priority programme for India, given that India is one of the 20 countries with high burden of TB. Odisha (a state in Eastern India) in 2017 reported 159/lakh/year cases as against a national average inci …
National Tuberculosis Elimination Programme (NTEP) is a priority programme for India, given that India is one of the 20 countr …
5,483 results